SEC Form 4 · accession 0001445064-15-000076
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Scholz
Officer — SVP, Global Operations
Period of report
Apr 1, 2015
Accepted (ET)
Apr 2, 2015 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Apr 1, 2015 | F | 143 | $124.72 | D | 22,844 | D |
Table II — derivative securities
No Table II lines on this filing.